Patent Assignment
Reel/Frame 024239/0315
Assignment of Assignor's Interest
Recorded: 2010-04-15
Pages: 7
Assignors
CUNNINGHAM, MELISSAN M.
Executed: 2000-10-11
STULL, PAUL D.
Executed: 2000-10-13
WEISBURG, WILLIAM G.
Executed: 2000-10-11
Assignee
GEN-PROBE INCORPORATED
10210 GENETIC CENTER DRIVE, MAIL STOP #1 / PATENT DEPT., SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Compositions and Methods for Detecting the Presence of Cryptosporidium Organisms in a Test Sample
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
Security Interest Release Reel/Frame 028810/0745
Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
Reel/Frame 035820/0239 →
Security Agreement
Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 028810 Frame: 0745. Assignor(S) Hereby Confirms the Security Agreement.
Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release.
Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
Reel/Frame 044727/0529 →
Release of Security Interest
Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 075566/0039 →